The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting
News
2025.11.20
*Notice* Revolutionizing Human Brain Disease Treatment! Yamaguchi University-Spun Startup ADDVEMO Launches in Earnest
News
2025.11.19
*Announcement* An external lecturer seminar will be held on Wednesday, January 28.
News
2025.10.24
*Report* In-house Seminar Held
News
2025.10.10
*Announcement* Yamaguchi University Public Lecture Series: “Living with Companion Animals” to be held on Sunday, November 16
News
2025.10.07
*Announcement* An in-house seminar will be held on Thursday, October 23.
News
2025.10.06
*Announcement* Symposium “Human and Animal Health: New Horizons Through the Integration of Human and Veterinary Medicine” Held
News
2025.09.02
*Notice* Yamaguchi Prefecture Launches New Certification System for Chronic Kidney Disease (CKD) Countermeasures ~“Cardiometabolic Care Physician” Program Aims to Prevent Disease Progression Through Enhanced Collaboration Between Primary Care Physicians and Specialists~
News
2025.09.02
*Report* In-House Seminar Held
Thesis
2025.11.12
CXCL8 mediates macrophage migration in canine oral malignant melanoma
Thesis
2025.10.08
Anastomotic leakage prevention using dry-preserved fibroblast cell sheets in esophageal reconstruction
Thesis
2025.09.29
Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma
Thesis
2025.09.08
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease
Thesis
2025.08.06
Comparison of post ablation left atrial volume index versus left atrial reverse remodeling for prognostic events in persistent atrial fibrillation
Thesis
2025.07.30
The future of Kawasaki disease management: data-driven innovations from bedside to bench and back again
Thesis
2025.07.28
Unsupervised identification of asthma symptom subtypes supports treatable traits approach
Thesis
2025.07.24
Wound-healing effects of frozen-thawed allogeneic fibroblast sheet transplantation and xenogeneic fibroblast cell sheet transplantation cultured on a new substrate
The article could not be found.
News
2025.11.20
*Notice* Revolutionizing Human Brain Disease Treatment! Yamaguchi University-Spun Startup ADDVEMO Launches in Earnest
News
2025.11.19
*Announcement* An external lecturer seminar will be held on Wednesday, January 28.
Thesis
2025.11.12
CXCL8 mediates macrophage migration in canine oral malignant melanoma
News
2025.10.24
*Report* In-house Seminar Held
News
2025.10.10
*Announcement* Yamaguchi University Public Lecture Series: “Living with Companion Animals” to be held on Sunday, November 16
Thesis
2025.10.08
Anastomotic leakage prevention using dry-preserved fibroblast cell sheets in esophageal reconstruction
News
2025.10.07
*Announcement* An in-house seminar will be held on Thursday, October 23.
News
2025.10.06
*Announcement* Symposium “Human and Animal Health: New Horizons Through the Integration of Human and Veterinary Medicine” Held
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー
